Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial [0.03%]
SWITCH研究：换用多替拉韦联合拉米夫定与继续三联抗逆转录病毒治疗在48周时病毒学抑制的HIV成人受试者中的非劣效性随机临床试验
Jhon Rojas,Elisa de Lazzari,Eugenia Negredo et al.
Jhon Rojas et al.
Background: Simplified antiretroviral therapy (ART) regimens are desirable for people with HIV. We investigated the efficacy and safety of switching from triple ART to dual dolutegravir plus lamivudine therapy. ...
Clinical Trial
The lancet. HIV. 2021 Aug;8(8):e463-e473. DOI:10.1016/S2352-3018(21)00100-4 2021
Christabel Ligami
Christabel Ligami
Philippa Harris,Richard Henderson,Peter Hayward
Philippa Harris
Christabel Ligami
Christabel Ligami
Mary Clare Masters,Susan Ellen Cohn
Mary Clare Masters
A second decade of PrEP [0.03%]
PrEP的第二个十年
The Lancet Hiv
The Lancet Hiv
Ann N Burchell,Troy Grennan
Ann N Burchell
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies [0.03%]
基于HIV状况、性取向和年龄的男性肛门人乳头瘤病毒感染及高度鳞状上皮内病变流行病学：64项研究合作汇总分析（29900名男性）
Feixue Wei,Michael M Gaisa,Gypsyamber D&#x;Souza et al.
Feixue Wei et al.
Background: Robust age-specific estimates of anal human papillomavirus (HPV) and high-grade squamous intraepithelial lesions (HSIL) in men can inform anal cancer prevention efforts. We aimed to evaluate the age-specific p...
Vivek Jain,Maya Petersen,Diane V Havlir
Vivek Jain
Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional study [0.03%]
印度关键人群中可检测到的人口水平HIV病毒血症的变化及其与HIV发病率的关系：一项连续横断面研究
Eshan U Patel,Sunil S Solomon,Gregory M Lucas et al.
Eshan U Patel et al.
Background: Population-level prevalence of detectable HIV viraemia (PDV) has been proposed as a metric for monitoring the population-level effectiveness of HIV treatment as prevention. We aimed to characterise temporal ch...